Skip to main content

Gyne-Lotrimin 3 Day Side Effects

Generic name: clotrimazole topical

Medically reviewed by Drugs.com. Last updated on May 10, 2024.

Note: This document provides detailed information about Gyne-Lotrimin 3 Day Side Effects associated with clotrimazole topical. Some dosage forms listed on this page may not apply specifically to the brand name Gyne-Lotrimin 3 Day.

Applies to clotrimazole topical: topical cream, topical lotion, topical solution.

Serious side effects of Gyne-Lotrimin 3 Day

Along with its needed effects, clotrimazole topical (the active ingredient contained in Gyne-Lotrimin 3 Day) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor as soon as possible if any of the following side effects occur while taking clotrimazole topical:

Managing side effects (general information)

For healthcare professionals

Applies to clotrimazole topical: compounding powder, topical cream, topical lotion, topical ointment, topical powder, topical solution, topical spray, vaginal cream with applicator, vaginal kit, vaginal tablet.

Dermatologic adverse events

Dermatologic side effects have included erythema, stinging, blistering, peeling, edema, itching, burning, and general skin irritation. Contact dermatitis, confirmed by patch testing, has been documented.[Ref]

Genitourinary

Genitourinary system effects associated with intravaginal use have included burning, itching, cramping, pain, and bleeding. Vulvar lesions and rash have rarely been reported.[Ref]

References

1. Roller JA (1978) "Contact allergy to clotrimazole." Br Med J, 2, p. 737

2. Balato N, Lembo G, Nappa P, Ayala F (1985) "Contact dermatitis from clotrimazole." Contact Dermatitis, 12, p. 110

3. Kalb RE, Grossman ME (1985) "Contact dermatitis to clotrimazole." Cutis, 36, p. 240-2

4. (2001) "Product Information. Mycelex (clotrimazole)." Bayer

5. Baes H (1995) "Contact dermatitis from clotrimazole." Contact Dermatitis, 32, p. 187-8

6. Lebherz T, Guess E, Wolfson N (1985) "Efficacy of single- versus multiple-dose clotrimazole therapy in the management of vulvovaginal candidiasis." Am J Obstet Gynecol, 152, p. 965-8

7. Wolfson N, Riley J, Samuels B, Singh JM (1981) "Clinical toxicology of clotrimazole when administered vaginally." Clin Toxicol, 18, p. 41-5

8. Pons V, Greenspan D, Debruin M (1993) "Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group." J Acquir Immune Defic Syndr, 6, p. 1311-6

9. Brown D Jr, Binder GL, Gardner HL, Wells J (1980) "Comparison of econazole and clotrimazole in the treatment of vulvovaginal candidiasis." Obstet Gynecol, 56, p. 121-3

10. Lebherz TB, Ford LC, Kleinkopf V (1981) "A comparison of a three-day and seven-day clotrimazole regimen for vulvovaginal candidiasis." Clin Ther, 3, p. 344-8

11. Stein GE, Christensen S, Mummaw N (1991) "Comparative study of fluconazole and clotrimazole in the treatment of vulvovaginal candidiasis." DICP, 25, p. 582-5

12. Sawyer PR, Brogden RN, Pinder RM, Speight TM, Avery (1975) "Clotrimazole: a review of its antifungal activity and therapeutic efficacy." Drugs, 9, p. 424-47

Frequently asked questions

Further information

Gyne-Lotrimin 3 Day side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer